Category:
Carcinomas
Cancer type:
Ovarian
Descriptor:
In vitro studies
Reference Number:
108
Wong, A. S. et al. Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
Oncogene 20, 1318-28. (2001).
PubMed link
Reference Number:
321
Rasola A, Anguissola S, Ferrero N, Gramaglia D, Maffe A, Maggiora P, Comoglio PM, Di Renzo MF. Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin.
Cancer Res 64, 1744-50 (2004)
PubMed link
Reference Number:
324
Crouch S, Spidel CS, Lindsey JS. HGF and ligation of alphavbeta5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering.
Exp Cell Res 292, 274-87 (2004)
PubMed link
Reference Number:
379
Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N, Meininger D, Hoey T, Austin RJ. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.
Biochem J. 390, 125-36 (2005)
PubMed link
Reference Number:
401
Zhou HY, Wong AS. Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.
Endocrinology. 147, 2557-66. Epub 2006 Feb 9. (2006)
PubMed link
Reference Number:
465
Coltella N, Rasola A, Nano E, Bardella C, Fassetta M, Filigheddu N, Graziani A, Comoglio PM, Di Renzo MF. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis.
Int J Cancer. 118, 2981-90 (2006)
PubMed link
